Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 50,000 shares of the business's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the completion of the sale, the insider directly owned 9,839,071 shares of the company's stock, valued at approximately $129,088,611.52. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Arteris Stock Down 5.9%
Shares of Arteris stock traded down $0.58 during trading on Thursday, reaching $9.31. 2,288,956 shares of the stock were exchanged, compared to its average volume of 535,557. The firm has a market cap of $390.83 million, a price-to-earnings ratio of -11.35 and a beta of 1.45. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $14.29. The stock's fifty day moving average is $9.09 and its 200 day moving average is $8.40.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Needham Investment Management LLC grew its position in shares of Arteris by 2.5% in the 1st quarter. Needham Investment Management LLC now owns 2,812,500 shares of the company's stock worth $19,434,000 after buying an additional 67,500 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Arteris by 9.6% in the second quarter. Acadian Asset Management LLC now owns 987,011 shares of the company's stock worth $9,403,000 after acquiring an additional 86,288 shares during the period. Next Century Growth Investors LLC boosted its holdings in Arteris by 46.4% in the first quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock valued at $2,817,000 after acquiring an additional 129,143 shares in the last quarter. Federated Hermes Inc. boosted its holdings in Arteris by 97.2% in the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock valued at $2,260,000 after acquiring an additional 161,241 shares in the last quarter. Finally, Roubaix Capital LLC increased its position in Arteris by 33.2% during the 1st quarter. Roubaix Capital LLC now owns 281,450 shares of the company's stock valued at $1,945,000 after purchasing an additional 70,111 shares during the period. Institutional investors own 64.36% of the company's stock.
Analyst Ratings Changes
AIP has been the topic of a number of analyst reports. TD Cowen lifted their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday. Rosenblatt Securities restated a "buy" rating and issued a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st.
Read Our Latest Stock Report on AIP
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.